The largest database of trusted experimental protocols

Lookout mycoplasma pcr kit

Manufactured by Merck Group
Sourced in United States

The LookOut Mycoplasma PCR Kit is a laboratory product designed for the detection of mycoplasma contamination in cell cultures. The kit utilizes polymerase chain reaction (PCR) technology to identify the presence of mycoplasma species. It provides a reliable and efficient method for monitoring cell culture purity.

Automatically generated - may contain errors

14 protocols using lookout mycoplasma pcr kit

1

Establishing Pancreatic Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
1473-2-AMK, 1108-2C926, 1319-3-NE, 1925 2-BHG and 950-5-BLK cells were isolated from patient derived xenografts (PDXs) from MGH pancreatic tumor bank. All study participants provided IRB-approved informed consent for their medical records and tissue samples to be used in this study. Patient clinical data was entered into a de-identified clinical database allowing for the anonymous analysis of demographic, clinical and pathological variables. PDXs were processed as described above and 2D cultures were established in 10% FBS, 1% Pen-strep DMEM-F12. PL45, YAPC, PANC-1 and PaTu-8889T PDA cells are from ATCC repository and were maintained in the same media. The absence of mycoplasma contamination of all the cell lines used in the study was verified by routine testing with LookOut Mycoplasma PCR Kit (Sigma, MP0035).
+ Open protocol
+ Expand
2

Establishing Pancreatic Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
1473-2-AMK, 1108-2C926, 1319-3-NE, 1925 2-BHG and 950-5-BLK cells were isolated from patient derived xenografts (PDXs) from MGH pancreatic tumor bank. All study participants provided IRB-approved informed consent for their medical records and tissue samples to be used in this study. Patient clinical data was entered into a de-identified clinical database allowing for the anonymous analysis of demographic, clinical and pathological variables. PDXs were processed as described above and 2D cultures were established in 10% FBS, 1% Pen-strep DMEM-F12. PL45, YAPC, PANC-1 and PaTu-8889T PDA cells are from ATCC repository and were maintained in the same media. The absence of mycoplasma contamination of all the cell lines used in the study was verified by routine testing with LookOut Mycoplasma PCR Kit (Sigma, MP0035).
+ Open protocol
+ Expand
3

Cell Culture Protocols for HEK293T and Murine ES Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were purchased from ATCC (CRL11268) and were cultured in DMEM (Gibco 11995) supplemented with 10% (v/v) fetal bovine serum (Gibco), 1% penicillin and streptomycin (Gibco) and grown at 37 ˚C with 5% CO2. Murine embryonic stem (ES) cells were purchased from ATCC (CRL-1821) and were cultured in DMEM (Gibco 11995) supplemented with 10% (v/v) fetal bovine serum (Gibco), 1 mM L-glutamine (Gibco), 0.1 mM β-mercaptoethanol (Gibco), 1% (v/v) nonessential amino acid stock (100×, Gibco), 1% penicillin/streptomycin stock (100×, Gibco), and 1,000 U/mL LIF (Millipore).
Cell lines used in this study were examined for mycoplasma contamination test using LookOut Mycoplasma PCR Kit (Sigma, MP0035).
+ Open protocol
+ Expand
4

Establishing Authenticated Cell Line and Tissue Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines were obtained from the American Type Culture Collection. Patient-derived PDA cultures were generated at Massachusetts General Hospital (MGH). Informed consent was obtained from all subjects. STR profiling was performed for all cell lines by the MGH Center for Molecular Therapeutics). Primary human samples and PDA cell lines were generated from ascites fluid under IRB approved protocols 02–240 and 2007P001918 (see also Supplemental Table S4). All lines used had verified activating KRAS mutations. Cells were cultured in the following media: 8988T, Panc1, PL18, PSN1, 8902, in DMEM supplemented with 10% FBS; HupT3, KLM1 in RPMI with 10% FBS; HPDE cells were cultured as described previously30 (link). Negative mycoplasma contamination status of all cell lines and primary cells used in the study was established using LookOut Mycoplasma PCR Kit (Sigma, MP0035).
+ Open protocol
+ Expand
5

Maintaining Human Cell Lines for Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T human embryonic kidney cells, HCT116 human colon carcinoma cells (containing wild-type p53: p53wt/wt HCT116, further noted as HCT116; lacking p53: p53−/− HCT116 and p53R248/− HCT116, a kind gift from Prof. Karen Vousden, Glasgow), and the human colon cancer cell line LIM1215 (a kind gift from Prof. Sabine Tejpar, Leuven) were maintained at 37°C at 95% air and 5% CO2 in DMEM (Gibco, life technologies) supplemented with 10% fetal bovine serum (FBS, Gibco), 2 mM l-glutamine (Gibco), and 1% penicillin/streptomycin (PenStrep, Gibco). All cancer cell lines underwent mycoplasma testing before their use. Negative mycoplasma contamination status was verified using LookOut Mycoplasma PCR Kit (Sigma) and MycoAlert Mycoplasma Detection Kit plus Assay Control (Lonza). All cell lines were not maintained longer than 10 passages in culture to perform experimental procedures. Transfection of siRNA was performed with lipofectamine RNAiMAX (Life Technologies) according to the supplier’s protocol. Catalog numbers for the different siRNAs used can be found in Table 1.
+ Open protocol
+ Expand
6

Characterization of REDD1 Null and KRAS Mutant Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The REDD1−/− allele was generated as previously described (Sofer et al. 2005 (link)). MEFs not harboring LSL-KrasG12D were immortalized by retroviral transduction of SV40 large T-antigen unless indicated otherwise, and were maintained in DMEM/10% FCS/Pen/Strep. Human non-small cell lung cancer cell line A549 was obtained from the American Type Culture Collection and maintained in DMEM/10% FCS/pen/strep. Primary pancreatic intraepithelial cells (AH375) were isolated from LSL-KRASG12D mice as described previously (Corcoran et al. 2011 (link)). All pancreatic ductal epithelial cells were routinely maintained in ductal media on laminin-coated plates. Negative mycoplasma contamination status of all cancer cell lines, 293T cell line and primary cells used in the study was established using LookOut mycoplasma PCR kit (Sigma MP0035).
+ Open protocol
+ Expand
7

Cell Culture Protocols for HEK293T and Murine ES Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were purchased from ATCC (CRL11268) and were cultured in DMEM (Gibco 11995) supplemented with 10% (v/v) fetal bovine serum (Gibco), 1% penicillin and streptomycin (Gibco) and grown at 37 ˚C with 5% CO2. Murine embryonic stem (ES) cells were purchased from ATCC (CRL-1821) and were cultured in DMEM (Gibco 11995) supplemented with 10% (v/v) fetal bovine serum (Gibco), 1 mM L-glutamine (Gibco), 0.1 mM β-mercaptoethanol (Gibco), 1% (v/v) nonessential amino acid stock (100×, Gibco), 1% penicillin/streptomycin stock (100×, Gibco), and 1,000 U/mL LIF (Millipore).
Cell lines used in this study were examined for mycoplasma contamination test using LookOut Mycoplasma PCR Kit (Sigma, MP0035).
+ Open protocol
+ Expand
8

Comparative Evaluation of Glioma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human glioma cells line viz, LN-18, U87MG, SNB-19, and U-251 were procured from ATCC and cultured in ATCC-recommended complete media. Whereas human neural glial cell-line (HNGC-2) and primary culture derived from GBM tumors (G1) were generated at National Centre for Cell Science (NCCS), Pune. Experimental methods on established patient-derived xenograft (PDX) cells CNXF-2599L were conducted at Charles River, Germany. The cells were maintained in a humidified chamber at 37 °C and 5% CO2. All the compounds were dissolved in dimethyl sulfoxide (DMSO) at a concentration of 10 mM and diluted in a culture medium immediately before use. Pyronaridine tetraphosphate (#VIA-404019) was procured from Chemical Centre (Mumbai, India) while Doxorubicin and Ritonavir were available in-house. Dulbecco’s phosphate-buffered saline without calcium and magnesium (#14025092), cell culture media, and FBS (#26140079) were purchased from Gibco (Thermofisher, Waltham, MA, USA). Lookout mycoplasma PCR kit (#MP0035) and PMS (#P9625) were from Sigma while 96-well flat-bottomed white polystyrene plates were from Corning (#3912) and MTS reagent from Promega (Madison, WI, USA, #G111).
+ Open protocol
+ Expand
9

Cell Lines Culture and Authentication

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells, HepG2 cells, MDA-MB-231cells and HEK293T cells were purchased from ATCC. HeLa cells were cultured in DMEM (Gibco 11965) supplemented with 10% (v/v) fetal bovine serum (Gibco), penicillin and streptomycin (Gibco) and grown at 37 °C with 5% CO2. HepG2, HEK293T cells were cultured in DMEM (Gibco 11995) supplemented with 10% (v/v) fetal bovine serum (Gibco), penicillin and streptomycin (Gibco) and grown at 37 °C with 5% CO2. 143B cells, Rho zero 143B cells are gift from Dr. Y. H. Wei. Hypoxia treated cells were incubated at 37 °C, 5% CO2 and 2.3% O2. Primary fibroblasts were isolated from postnatal 0-to 4-day-old wild-type mice. The skin tissue was isolated and cut into small pieces in PBS with penicillin and streptomycin. These pieces were attached to 10 cm FBS-coated dishes (one mouse for one dish) and cultured in medium containing DMEM supplemented with 10% FBS, 1mM L-glutamine, 100 IU/mL penicillin and streptomycin. Cells were grown at 37 °C in 5% CO2. As a part of cell authentication, cell lines used in this study were examined by mycoplasma contamination test using LookOut Mycoplasma PCR Kit (Sigma, MP0035).
+ Open protocol
+ Expand
10

Establishing Authenticated Cell Line and Tissue Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines were obtained from the American Type Culture Collection. Patient-derived PDA cultures were generated at Massachusetts General Hospital (MGH). Informed consent was obtained from all subjects. STR profiling was performed for all cell lines by the MGH Center for Molecular Therapeutics). Primary human samples and PDA cell lines were generated from ascites fluid under IRB approved protocols 02–240 and 2007P001918 (see also Supplemental Table S4). All lines used had verified activating KRAS mutations. Cells were cultured in the following media: 8988T, Panc1, PL18, PSN1, 8902, in DMEM supplemented with 10% FBS; HupT3, KLM1 in RPMI with 10% FBS; HPDE cells were cultured as described previously30 (link). Negative mycoplasma contamination status of all cell lines and primary cells used in the study was established using LookOut Mycoplasma PCR Kit (Sigma, MP0035).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!